Active, Not Recruiting
A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)
NCT02942290
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Duplicate_University of Arizona Cancer Center - North Campus /ID# 154155 Tucson, Arizona, United States
- The University of Chicago Medical Center /ID# 153673 Chicago, Illinois, United States
- University of Maryland, Baltimore /ID# 153669 Baltimore, Maryland, United States
- Tufts Medical Center /ID# 153672 Boston, Massachusetts, United States